JAMP-EFAVIRENZ
Identification of Jamp-Efavirenz
| No description |
Google image searchProduct monograph
Active ingredient
efavirenz, 600 MG
DIN: 02458233
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 14-JUN-2019
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AG — Non-nucleoside reverse transcriptase inhibitors (ATC, ATC/DDD)
- J05AG03 — EFAVIRENZ (ATC/DDD)
Reference brand drug: Sustiva
Pharmaceutical standard: USP
